Applied Therapeutics, Inc.
APLT
$0.5143
$0.00020.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 100.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 100.00% | -- | -- |
| Cost of Revenue | -0.81% | -35.85% | -23.58% | 37.49% | -15.81% |
| Gross Profit | -0.64% | 34.84% | 26.77% | -36.36% | 17.02% |
| SG&A Expenses | 24.53% | 95.10% | 323.32% | 219.26% | 99.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.21% | 19.93% | 62.34% | 92.74% | 19.84% |
| Operating Income | -13.00% | -21.01% | -57.19% | -91.95% | -19.00% |
| Income Before Tax | -836.02% | 74.00% | 216.79% | -61.89% | 109.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -836.02% | 74.00% | 216.79% | -61.89% | 109.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -836.02% | 74.00% | 216.79% | -61.89% | 109.80% |
| EBIT | -13.00% | -21.01% | -57.19% | -91.95% | -19.00% |
| EBITDA | -13.00% | -21.02% | -57.19% | -91.95% | -19.01% |
| EPS Basic | -831.34% | 77.50% | 189.35% | -1.69% | 105.37% |
| Normalized Basic EPS | -829.37% | 77.50% | 189.52% | -1.64% | 105.39% |
| EPS Diluted | -15.21% | 77.50% | 188.50% | -1.69% | 65.21% |
| Normalized Diluted EPS | -872.27% | 77.50% | 189.52% | -1.64% | 105.09% |
| Average Basic Shares Outstanding | 0.80% | 15.54% | 30.70% | 59.20% | 82.10% |
| Average Diluted Shares Outstanding | -4.79% | 15.54% | 30.70% | 59.20% | 92.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |